Noticias de Eulerpool Precision BioSciences

Precision BioSciences Noticias de Acciones

Precision BioSciences es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Precision BioSciences.

• 14 de mayo ·

  Yahoo
  Precision BioSciences Accelerates Development of PBGENE-DMD Within its Wholly Owned Organic Pipeline and Highlights Pre-clinical Evidence at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
• 26 de marzo ·

  Yahoo
  Precision BioSciences: Q4 Earnings Snapshot
• 21 de marzo ·

  Yahoo
  Precision BioSciences to Report Fourth Quarter and Fiscal Year 2024 Results on March 26, 2025
• 20 de marzo ·

  Yahoo
  Precision BioSciences Presents Preclinical Safety and Efficacy Data Supporting Repeat Dosing of PBGENE-HBV With a Goal of Curing Chronic Hepatitis B at the Global Hepatitis Summit 2025
• 19 de marzo ·

  Yahoo
  Precision BioSciences Presents Preclinical Efficacy and Durability Data on PBGENE-DMD for the Treatment of Duchenne Muscular Dystrophy (DMD) at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
• 17 de marzo ·

  Yahoo
  Precision BioSciences Announces Clearance of Investigational New Drug Application by the U.S. FDA for First-in-Class PBGENE-HBV Designed to Eliminate Root Cause of Chronic Hepatitis B
• 15 de marzo ·

  SeekingAlpha
  Precision & TG Therapeutics: Unlocking Value With ARCUS, BRIUMVI And Azer-Cel
• 24 de febrero ·

  Yahoo
  Precision BioSciences Announces Oral Presentation at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
• 20 de febrero ·

  Yahoo
  Precision reports initial outcomes from Hepatitis B trial of PBGENE-HBV
• 19 de febrero ·

  Yahoo
  Precision BioSciences Touts Encouraging Initial Safety And Antiviral Activity Of Hepatitis B Treatment Candidate